Psychiatry and Neurology, Neurology · Houston, TX
NPI
1417121245
Since 2008
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
6410 Fannin St Ste 1014
Houston, TX, 77030
Phone (832) 325-7080
Groups this clinician bills Medicare through
Medicare paid, 2024
$105K
2,124 services
Medicare patients, 2024
96
Average age 66
Drug cost, 2024
$4.7M
2,230 prescriptions
Company payments, 2025
$17K
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John A Lincoln was code 99215 (office e&m - established), 98 times for 62 patients. In total John A Lincoln billed 2,124 services in 21 codes, and Medicare paid $105K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-05-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 98 | 62 | $124.29 | $12K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 80 | 58 | $12.31 | $985 |
| 99214 Office E&M - Established | Office | 13 | 13 | $79.08 | $1,028 |
By year: 2022 $168K for 3,267 services; 2023 $164K for 3,248 services; 2024 $105K for 2,124 services.
Medicare prescription drug claims, 2024
In 2024, the drug John A Lincoln prescribed most often to Medicare patients was Baclofen, with 226 prescriptions and refills. In total John A Lincoln wrote 2,230 Medicare prescriptions that cost $4.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 226 | 405 | 57 | $5,274 |
| Dalfampridine Er Dalfampridine | 215 | 283 | 34 | $133K |
| Gabapentin Generic | 122 | 206 | 34 | $1,815 |
| Duloxetine Hcl Generic | 90 | 161 | 21 | $1,547 |
| Carbamazepine Er Carbamazepine | 74 | 122 | 20 | $7,080 |
| Cyclobenzaprine Hcl Generic | 71 | 79 | 13 | $579 |
| Pregabalin Generic | 67 | 89 | 15 | $905 |
| Modafinil Generic | 65 | 83 | 12 | $2,365 |
| Teriflunomide Generic | 63 | 71 | Under 11 | $4,038 |
| Myrbetriq Mirabegron | 60 | 78 | 12 | $35K |
| Kesimpta Pen Ofatumumab | 48 | 50 | Under 11 | $433K |
| Amantadine Amantadine Hcl | 44 | 84 | 13 | $1,539 |
| Tizanidine Hcl Generic | 32 | 46 | Under 11 | $337 |
| Levetiracetam Generic | 32 | 75 | Under 11 | $1,527 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 31 | 69 | Under 11 | $550 |
Brand drugs: 397 claims; generic drugs: 1,833 claims; opioid claims: 48.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John A Lincoln $17K ($17K in general payments such as food, travel and fees) from 14 companies. The largest payer was Biogen, Inc. with $15K.
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. BIIB | 14 | $15K |
| TG Therapeutics, Inc. TGTX | 14 | $369 |
| Novartis Pharmaceuticals Corporation NVS | 14 | $293 |
| EMD Serono, Inc. MRK.DE | 9 | $288 |
| Vanda Pharmaceuticals Inc. VNDA | 7 | $224 |
| Celgene Corporation BMY | 8 | $156 |
| Amgen Inc. AMGN | 4 | $104 |
| Pfizer Inc. PFE | 3 | $67.1 |
| UCB, Inc. UCB.BR | 2 | $61.76 |
| Genentech USA, Inc. ROG.SW | 2 | $42.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.